These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 32582959)
1. MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer. Li K; Yuan C Int J Mol Med; 2020 Sep; 46(3):1013-1028. PubMed ID: 32582959 [TBL] [Abstract][Full Text] [Related]
2. STAT3-induced long noncoding RNA LINC00668 promotes migration and invasion of non-small cell lung cancer via the miR-193a/KLF7 axis. An YX; Shang YJ; Xu ZW; Zhang QC; Wang Z; Xuan WX; Zhang XJ Biomed Pharmacother; 2019 Aug; 116():109023. PubMed ID: 31150989 [TBL] [Abstract][Full Text] [Related]
3. miR-185 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer by Targeting KLF7. Zhao L; Zhang Y; Liu J; Yin W; Jin D; Wang D; Zhang W Oncol Res; 2019 Sep; 27(9):1015-1023. PubMed ID: 29716672 [TBL] [Abstract][Full Text] [Related]
4. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
5. MicroRNA-625 inhibits the progression of non‑small cell lung cancer by directly targeting HOXB5 and deactivating the Wnt/β-catenin pathway. Tan X; Jiang L; Wu X; Feng W; Lin Q Int J Mol Med; 2019 Jul; 44(1):346-356. PubMed ID: 31115501 [TBL] [Abstract][Full Text] [Related]
6. miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells. Tang Q; Li M; Chen L; Bi F; Xia H Int J Oncol; 2018 Oct; 53(4):1732-1742. PubMed ID: 30066855 [TBL] [Abstract][Full Text] [Related]
7. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway. Zhao M; Ma W; Ma C Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951 [TBL] [Abstract][Full Text] [Related]
8. Silencing of Zhang P; Li Z; Yang G Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300 [TBL] [Abstract][Full Text] [Related]
9. miR‑454‑3p inhibits non‑small cell lung cancer cell proliferation and metastasis by targeting TGFB2. Liao H; Liang Y; Kang L; Xiao Y; Yu T; Wan R Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760169 [TBL] [Abstract][Full Text] [Related]
10. ΜicroRNA‑421 promotes the progression of non‑small cell lung cancer by targeting HOPX and regulating the Wnt/β‑catenin signaling pathway. Liang H; Wang C; Gao K; Li J; Jia R Mol Med Rep; 2019 Jul; 20(1):151-161. PubMed ID: 31115507 [TBL] [Abstract][Full Text] [Related]
11. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression. Xue D; Yang P; Wei Q; Li X; Lin L; Lin T Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑92a promotes non‑small cell lung cancer cell growth by targeting tumor suppressor gene FBXW7. Ni D; Teng J; Cheng Y; Zhu Z; Zhuang B; Yang Z Mol Med Rep; 2020 Oct; 22(4):2817-2825. PubMed ID: 32945381 [TBL] [Abstract][Full Text] [Related]
13. Propofol suppresses the progression of non‑small cell lung cancer via downregulation of the miR‑21‑5p/MAPK10 axis. Wu X; Li X; Xu G Oncol Rep; 2020 Aug; 44(2):487-498. PubMed ID: 32468043 [TBL] [Abstract][Full Text] [Related]
14. NORAD regulates epithelial‑mesenchymal transition of non‑small cell lung cancer cells via miR‑422a. Chen Z; Che Q; Xie C Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300080 [TBL] [Abstract][Full Text] [Related]
15. Long non‑coding RNA SNHG3 promotes the development of non‑small cell lung cancer via the miR‑1343‑3p/NFIX pathway. Zhao L; Song X; Guo Y; Ding N; Wang T; Huang L Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34132359 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑103 regulates tumorigenesis in colorectal cancer by targeting ZO‑1. Ke J; Shao W; Jiang Y; Xu J; Li F; Qin J Mol Med Rep; 2018 Jan; 17(1):783-788. PubMed ID: 29115525 [TBL] [Abstract][Full Text] [Related]
17. miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells. Tang H; Lv W; Sun W; Bi Q; Hao Y Int J Mol Med; 2019 Mar; 43(3):1203-1216. PubMed ID: 30628663 [TBL] [Abstract][Full Text] [Related]
18. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro. Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487 [TBL] [Abstract][Full Text] [Related]
19. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene. Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757 [TBL] [Abstract][Full Text] [Related]
20. miR-25 enhances cell migration and invasion in non-small-cell lung cancer cells via ERK signaling pathway by inhibiting KLF4. Ding X; Zhong T; Jiang L; Huang J; Xia Y; Hu R Mol Med Rep; 2018 May; 17(5):7005-7016. PubMed ID: 29568911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]